Business Description
Jia Jie Biomedical Co Ltd
ISIN : TW0004109004
Total Employee Number:
162Compare
Compare
Traded in other countries / regions
4109.Taiwan IPO Date
2002-08-08Description
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.88 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.4 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | 70.2 | |||||
3-Year FCF Growth Rate | -23.6 | |||||
3-Year Book Growth Rate | 13 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 26.31 | |||||
9-Day RSI | 34.08 | |||||
14-Day RSI | 39.11 | |||||
3-1 Month Momentum % | -3 | |||||
6-1 Month Momentum % | -20.7 | |||||
12-1 Month Momentum % | -25.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.08 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 3.45 | |||||
Days Inventory | 27.16 | |||||
Days Sales Outstanding | 30.63 | |||||
Days Payable | 17.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.46 | |||||
Dividend Payout Ratio | 1.09 | |||||
Forward Dividend Yield % | 4.46 | |||||
5-Year Yield-on-Cost % | 4.46 | |||||
3-Year Average Share Buyback Ratio | -9.1 | |||||
Shareholder Yield % | 2.33 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.86 | |||||
Operating Margin % | -1.5 | |||||
Net Margin % | 11.32 | |||||
EBITDA Margin % | 15.82 | |||||
FCF Margin % | -13.33 | |||||
OCF Margin % | 4.38 | |||||
ROE % | 3.33 | |||||
ROA % | 2.95 | |||||
ROIC % | -0.56 | |||||
3-Year ROIIC % | 2.2 | |||||
ROC (Joel Greenblatt) % | 12.64 | |||||
ROCE % | 3.44 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.24 | |||||
PE Ratio without NRI | 24.24 | |||||
Price-to-Owner-Earnings | 26.29 | |||||
PS Ratio | 2.71 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.83 | |||||
Price-to-Operating-Cash-Flow | 63.36 | |||||
EV-to-EBIT | 15.73 | |||||
EV-to-EBITDA | 11.97 | |||||
EV-to-Revenue | 1.9 | |||||
EV-to-FCF | -14.3 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 1.08 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
Price-to-Graham-Number | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 3.83 | |||||
| Price-to-Net-Cash | 5.23 | |||||
Earnings Yield (Greenblatt) % | 6.36 | |||||
FCF Yield % | -4.91 | |||||
Forward Rate of Return (Yacktman) % | -6.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jia Jie Biomedical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 487.664 | ||
| EPS (TTM) (NT$) | 0.46 | ||
| Beta | 0.2099 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 24.83 | ||
| 14-Day RSI | 39.11 | ||
| 14-Day ATR (NT$) | 0.332549 | ||
| 20-Day SMA (NT$) | 11.8025 | ||
| 12-1 Month Momentum % | -25.66 | ||
| 52-Week Range (NT$) | 10.35 - 18.8 | ||
| Shares Outstanding (Mil) | 118.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jia Jie Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jia Jie Biomedical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.500000 Cash Dividend | 2025-09-24 | 16.90 (+0.60%) | ||
| TWD 0.486555 Cash Dividend | 2024-08-26 | 31.09 (+1.75%) | ||
| 0.848783:1 Stock Split | 2019-03-21 | 20.01 (+3.87%) | ||
| 1.04:1 Stock Split | 2017-09-05 | 20.01 (-2.68%) | ||
| 1.05:1 Stock Split | 2016-09-12 | 22.99 (+0.00%) | ||
| 1.04028:1 Stock Split | 2015-09-14 | 22.86 (-4.23%) | ||
| 1.03853:1 Stock Split | 2014-09-24 | 25.85 (-0.37%) | ||
| 1.03976:1 Stock Split | 2013-09-24 | 21.84 (-3.43%) | ||
| 1.08:1 Stock Split | 2012-09-24 | 15.58 (-0.83%) | ||
| 1.05931:1 Stock Split | 2011-09-23 | 14.91 (+2.53%) |
Show
Entries
Jia Jie Biomedical Co Ltd Frequently Asked Questions
What is Jia Jie Biomedical Co Ltd(ROCO:4109)'s stock price today?
The current price of ROCO:4109 is NT$11.15. The 52 week high of ROCO:4109 is NT$18.80 and 52 week low is NT$10.35.
When is next earnings date of Jia Jie Biomedical Co Ltd(ROCO:4109)?
The next earnings date of Jia Jie Biomedical Co Ltd(ROCO:4109) is .
Does Jia Jie Biomedical Co Ltd(ROCO:4109) pay dividends? If so, how much?
The Dividend Yield %  of Jia Jie Biomedical Co Ltd(ROCO:4109) is 4.46% (As of Today), Highest Dividend Payout Ratio of Jia Jie Biomedical Co Ltd(ROCO:4109) was 1.3. The lowest was 0.23. And the median was 1.16. The  Forward Dividend Yield % of Jia Jie Biomedical Co Ltd(ROCO:4109) is 4.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jia Jie Biomedical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers